A group of pharmaceutical companies plan to work together to test existing and experimental cancer drugs, the Los Angeles Times reports. The National Immunotherapy Coalition, as the initiative is to be known, will be spearheaded by Thousand Oaks biotech giant Amgen, Los Angeles billionaire Dr. Patrick Soon-Shiong, several university cancer centers, and others.
According to the Los Angeles Times, the coalition will conduct dozens of small-scale clinical trials across the country over the next two to three years, followed by later-stage trials.
For reprint and licensing requests for this article, CLICK HERE.
Stories You May Also Be Interested In
- Amgen to Acquire Onyx for $10.4 Billion
- Billionaire’s Big Pay Revealed
- Amgen, Takeda's Cancer Drug Test Stopped After Deaths
- On the Way to IPO
- Tribune Publishing Shareholders Restless
- Amgen Gets Approval for Repatha
- Biotech Mogul Patrick Soon-Shiong to Launch Nant IPO
- Amgen Says Cancer Drug Trial to Resume